Women’s tennis players must take one-time gene test for eligibility
Summary
The Women’s Tennis Association (WTA) now requires female players to take a one-time gene test to confirm eligibility for women's tournaments. This test, looking for the SRY gene related to biological sex, will start in 2026 and replace the previous testosterone-level rule for transgender women.Key Facts
- The WTA updated its eligibility policy to include a one-time gene test for the SRY gene.
- The test can be done with a cheek swab or blood sample.
- The policy begins in 2026 with privacy protections and player engagement.
- Previously, transgender women could compete if they declared female gender and kept low testosterone for two years.
- No transgender women currently play professionally in women’s tennis.
- Other sports groups like World Athletics and World Boxing also use similar gene tests.
- The International Olympic Committee now requires a one-time biological sex test for female categories.
- Some former players and athletes have differing views on transgender inclusion in women’s sports.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
